Physician Wealth Advisors’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-946
Closed -$7.95K 1933
2025
Q2
$7.95K Hold
946
﹤0.01% 689
2025
Q1
$8.79K Hold
946
﹤0.01% 630
2024
Q4
$21.3K Hold
946
﹤0.01% 494
2024
Q3
$35.8K Sell
946
-100
-10% -$3.84K 0.01% 183
2024
Q2
$41.4K Sell
1,046
-67
-6% -$2.44K 0.01% 182
2024
Q1
$39K Buy
1,113
+67
+6% +$2.43K 0.01% 176
2023
Q4
$39.5K Sell
1,046
-267
-20% -$9.41K 0.01% 167
2023
Q3
$41K Hold
1,313
0.01% 148
2023
Q2
$44.9K Hold
1,313
0.01% 149
2023
Q1
$58.7K Hold
1,313
0.02% 151
2022
Q4
$110K Buy
1,313
+184
+16% +$17.2K 0.03% 149
2022
Q3
$113K Buy
1,129
+183
+19% +$25.6K 0.03% 145
2022
Q2
$188K Sell
946
-400
-30% -$60.8K 0.05% 147
2022
Q1
$188K Buy
1,346
+200
+17% +$41.4K 0.05% 154
2021
Q4
$319K Buy
1,146
+133
+13% +$34.9K 0.08% 117
2021
Q3
$255K Sell
1,013
-100
-9% -$29.2K 0.07% 134
2021
Q2
$352K Buy
1,113
+40
+4% +$10.3K 0.1% 104
2021
Q1
$303K Buy
+1,073
New +$428K 0.1% 110

Other funds holding CODX

Physician Wealth Advisors's CODX Position: Q3 2025 in Review

Physician Wealth Advisors sold out of Co-Diagnostics (CODX) in Q3 2025, closing a stake of 946 shares — an estimated $7.95K sold.

Physician Wealth Advisors first reported a position in CODX in Q1 2021 and held it in 18 quarters. The position peaked at $352K in Q2 2021. 33 funds tracked by Wall St. Rank hold CODX as of Q3 2025.

  • Physician Wealth Advisors reported no remaining Co-Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Physician Wealth Advisors sold 946 Co-Diagnostics shares in Q3 2025, an estimated $7.95K.
  • Physician Wealth Advisors first reported a position in Co-Diagnostics in Q1 2021 and held it in 18 quarters.
  • Physician Wealth Advisors's Co-Diagnostics position peaked at $352K in Q2 2021.
  • 33 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2025.

Based on Physician Wealth Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.